As of 2024-12-15, the EV/EBITDA ratio of Inspire Medical Systems Inc (INSP) is 295.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSP's latest enterprise value is 5,481.75 mil USD. INSP's TTM EBITDA according to its financial statements is 18.58 mil USD. Dividing these 2 quantities gives us the above INSP EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 33.5x | 30.5x |
| Forward P/E multiples | 30.7x - 45.2x | 38.7x |
| Fair Price | 18.23 - 32.93 | 26.37 |
| Upside | -90.3% - -82.5% | -86.0% |
| Date | EV/EBITDA |
| 2024-12-13 | 295.10 |
| 2024-12-12 | 298.54 |
| 2024-12-11 | 303.00 |
| 2024-12-10 | 297.60 |
| 2024-12-09 | 297.76 |
| 2024-12-06 | 303.42 |
| 2024-12-05 | 301.12 |
| 2024-12-04 | 309.70 |
| 2024-12-03 | 301.60 |
| 2024-12-02 | 296.15 |
| 2024-11-29 | 302.99 |
| 2024-11-27 | 304.99 |
| 2024-11-26 | 297.13 |
| 2024-11-25 | 313.57 |
| 2024-11-22 | 296.49 |
| 2024-11-21 | 292.39 |
| 2024-11-20 | 290.10 |
| 2024-11-19 | 276.03 |
| 2024-11-18 | 274.79 |
| 2024-11-15 | 270.63 |
| 2024-11-14 | 271.00 |
| 2024-11-13 | 285.92 |
| 2024-11-12 | 299.75 |
| 2024-11-11 | 317.96 |
| 2024-11-08 | 309.21 |
| 2024-11-07 | 315.42 |
| 2024-11-06 | 333.43 |
| 2024-11-05 | 313.05 |
| 2024-11-04 | 302.91 |
| 2024-11-01 | 299.68 |
| 2024-10-31 | 306.67 |
| 2024-10-30 | 309.12 |
| 2024-10-29 | 313.21 |
| 2024-10-28 | 306.08 |
| 2024-10-25 | 306.92 |
| 2024-10-24 | 307.08 |
| 2024-10-23 | 302.52 |
| 2024-10-22 | 310.68 |
| 2024-10-21 | 320.23 |
| 2024-10-18 | 317.54 |
| 2024-10-17 | 310.12 |
| 2024-10-16 | 308.60 |
| 2024-10-15 | 312.94 |
| 2024-10-14 | 331.54 |
| 2024-10-11 | 332.13 |
| 2024-10-10 | 323.44 |
| 2024-10-09 | 325.84 |
| 2024-10-08 | 325.49 |
| 2024-10-07 | 326.28 |
| 2024-10-04 | 338.75 |